Mission Pharmacal
Privately held pharmaceutical company based in San Antonio, Texas, operating since 1946. Develops, manufactures, and commercializes branded prescription, over-the-counter, generic, and related healthcare products with capabilities in formulation development, analytical testing, regulatory support, and contract development and manufacturing (CDMO) from a GMP, FDA-registered campus in Boerne, Texas.
Industries
Nr. of Employees
medium (51-250)
Mission Pharmacal
San Antonio, Texas, United States
Patents
Sprayable composition containing zinc oxide and a fluoro-olefin propellant
US-11007151-B2
View Details
Sprayable composition containing zinc oxide and a fluoro-olefin propellant
US-11007151-B2
View DetailsProducts
Branded prescription products and OTC portfolio
Branded prescription and over-the-counter products marketed across therapeutic areas with commercial sales and distribution infrastructure; product focus areas include women’s health, urology, and dermatology.
Generic pharmaceuticals and dietary supplement offerings
Generic drug products and dietary supplements supported by commercialization and distribution services.
Branded prescription products and OTC portfolio
Branded prescription and over-the-counter products marketed across therapeutic areas with commercial sales and distribution infrastructure; product focus areas include women’s health, urology, and dermatology.
Generic pharmaceuticals and dietary supplement offerings
Generic drug products and dietary supplements supported by commercialization and distribution services.
Services
End-to-end manufacturing and development services for prescription, OTC and medical device products including development, analytical testing, regulatory support, manufacturing and packaging; customizable offerings for projects at any lifecycle stage.
In-process and release testing, method transfer, stability testing, USP/NF testing, cleaning validation and analytical method development and validation performed in a cGMP laboratory.
Regulatory strategy, agency meeting support, document quality review, eCTD preparation and publishing, labeling strategy, CMC authoring and pharmacovigilance support.
Turnkey and à la carte services for generic products including labeling coordination, warehousing, fully-licensed U.S. distribution, national account sales management, EDI and accounting support.
End-to-end manufacturing and development services for prescription, OTC and medical device products including development, analytical testing, regulatory support, manufacturing and packaging; customizable offerings for projects at any lifecycle stage.
In-process and release testing, method transfer, stability testing, USP/NF testing, cleaning validation and analytical method development and validation performed in a cGMP laboratory.
Regulatory strategy, agency meeting support, document quality review, eCTD preparation and publishing, labeling strategy, CMC authoring and pharmacovigilance support.
Turnkey and à la carte services for generic products including labeling coordination, warehousing, fully-licensed U.S. distribution, national account sales management, EDI and accounting support.
Expertise Areas
- Contract development and manufacturing (CDMO)
- Formulation development for oral and topical dosage forms
- Analytical testing and method validation
- Regulatory compliance and eCTD submissions
Key Technologies
- cGMP manufacturing
- High-shear mixing
- Fluid-bed granulation
- Direct compression
News & Updates
Earned Drug Distributor Accreditation demonstrating compliance with distribution criteria and practices intended to prevent counterfeit or diverted drugs from entering the U.S. supply chain.
Historical expansions include opening a 100,000 sq. ft. manufacturing center (1990s) and later expansion of the Boerne complex to more than 300,000 sq. ft.; construction of a 30,000 sq. ft. R&D facility in Boerne (2000s).
Earned Drug Distributor Accreditation demonstrating compliance with distribution criteria and practices intended to prevent counterfeit or diverted drugs from entering the U.S. supply chain.
Historical expansions include opening a 100,000 sq. ft. manufacturing center (1990s) and later expansion of the Boerne complex to more than 300,000 sq. ft.; construction of a 30,000 sq. ft. R&D facility in Boerne (2000s).